The Worldwide Industry for Wearable Cardioverter Defibrillators is Expected to Reach Around $1.1 Billion by 2028
15 janv. 2021 08h03 HE
|
Research and Markets
Dublin, Jan. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Wearable Cardioverter Defibrillator Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering. The value of global...
Defibrillator Market Forecast Report 2020: Focus on US, Germany, Spain, Italy, France, United Kingdom and Japan
08 janv. 2021 06h38 HE
|
Research and Markets
Dublin, Jan. 08, 2021 (GLOBE NEWSWIRE) -- The "Defibrillator - Market Insights, Competitive Landscape and Market Forecast - 2025" report has been added to ResearchAndMarkets.com's offering. This...
Global $10.08 Billion Defibrillators (Implantable Cardioverter & External) Market Opportunity Analysis and Industry Forecast to 2026
14 sept. 2020 06h48 HE
|
Research and Markets
Dublin, Sept. 14, 2020 (GLOBE NEWSWIRE) -- The "Defibrillators Market by Type, and External Defibrillators), by End User, by Geography Global Opportunity Analysis and Industry Forecast up to 2026"...
CBRS Alliance Celebrates Availability of OnGo™ Service in 3.5 GHz CBRS Band at Pivotal Launch Event
18 sept. 2019 11h31 HE
|
CBRS Alliance
WASHINGTON, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Today, the CBRS Alliance, an industry organization focused on driving the development, commercialization, and adoption of OnGo™ shared spectrum...
FCC Authorizes Historic OnGo™ Deployments in 3.5 GHz CBRS Band, Opens Billions in Economic Opportunity for U.S.
16 sept. 2019 11h56 HE
|
CBRS Alliance
SUNNYVALE, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- The CBRS Alliance, an industry organization focused on driving the development, commercialization, and adoption of OnGo™ shared spectrum...
US FDA GRANTS PV-10 ORPHAN DRUG DESIGNATION FOR NEUROBLASTOMA
05 nov. 2018 08h00 HE
|
Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the Company was granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA)...
Heart Implant Patients' Fears About Shock Leads to Sexual Dysfunction
14 nov. 2011 10h10 HE
|
American Heart Association
Study Highlights:
Adults with congenital heart disease who have implanted defibrillators often have shock-related anxiety about the device delivering a shock during sex.
The anxiety can...